Rilpivirine (TMC278, trade name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.

CAS：500287-72-9
中文别名：(E)-4-(4-(4-(2-氰基乙烯基)-2,6-二甲基苯基氨基)嘧啶-2-基氨基)苯腈;利吡韦林;
英文别名：TMC-278;Edurant;4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile;UNII-FI96A8X663;Rilpivirine;[3H]-Rilpivirine;
分子式：C22H18N6
分子量：366.419
精确质量：366.159
Psa：97.42
Logp：5.13506

UNII：FI96A8X663

密度：1.27g/cm3
沸点：634.1ºC at 760 mmHg
熔点：245ºC
闪点：337.3ºC
折射率：1.665
储存条件：Refrigerator

海关编码：2933599090